2 news items
Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer
RGLS
16 May 24
such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking
Regulus Therapeutics Advances to Cohort 4 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RGLS
6 May 24
materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans
- Prev
- 1
- Next